Neutralization of Clostridium difficile Toxin B Mediated by Engineered Lactobacilli That Produce Single-Domain Antibodies.

MLA

Andersen, Kasper Krogh, et al. “Neutralization of Clostridium Difficile Toxin B Mediated by Engineered Lactobacilli That Produce Single-Domain Antibodies.” Infection and Immunity, vol. 84, no. 2, Nov. 2015, pp. 395–406. EBSCOhost, https://doi.org/10.1128/IAI.00870-15.

APA

Andersen, K. K., Strokappe, N. M., Hultberg, A., Truusalu, K., Smidt, I., Mikelsaar, R.-H., Mikelsaar, M., Verrips, T., Hammarström, L., & Marcotte, H. (2015). Neutralization of Clostridium difficile Toxin B Mediated by Engineered Lactobacilli That Produce Single-Domain Antibodies. Infection and Immunity, 84(2), 395–406. https://doi.org/10.1128/IAI.00870-15

Chicago

Andersen, Kasper Krogh, Nika M Strokappe, Anna Hultberg, Kai Truusalu, Imbi Smidt, Raik-Hiio Mikelsaar, Marika Mikelsaar, Theo Verrips, Lennart Hammarström, and Harold Marcotte. 2015. “Neutralization of Clostridium Difficile Toxin B Mediated by Engineered Lactobacilli That Produce Single-Domain Antibodies.” Infection and Immunity 84 (2): 395–406. doi:10.1128/IAI.00870-15.